Patents by Inventor Carl E. Wagner

Carl E. Wagner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230322688
    Abstract: The invention provides compounds formula (I) and salts thereof: wherein R1-R2 have any of the values defined in the specification. The compounds are useful for treating conditions including Alzheimer? s disease, Parkinson’s disease, diabetes, cancer, inflammation, hyperresponsiveness, allergic conditions, asthma, and psychotic disorders such as schizophrenia. The compounds are also useful to lower IL-4, IL-5, or IL-15 levels in an animal.
    Type: Application
    Filed: September 8, 2021
    Publication date: October 12, 2023
    Applicant: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Carl E. WAGNER, Peter W. JURUTKA, Pamela A. MARSHALL
  • Patent number: 10391093
    Abstract: The invention provides compounds of formulae I, II, III, and IV: and salts thereof, as well as pharmaceutical compositions comprising such compounds. The compounds are useful for treating cancers and Alzheimer's disease.
    Type: Grant
    Filed: January 4, 2017
    Date of Patent: August 27, 2019
    Assignee: ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Carl E. Wagner, Peter W. Jurutka, Pamela A. Marshall
  • Patent number: 10238655
    Abstract: The invention provides compounds of formula I: and salts thereof, as well as pharmaceutical compositions comprising such compounds. The compounds are useful for treating cancers, Alzheimer's disease, and conditions associated with demyelination.
    Type: Grant
    Filed: January 23, 2018
    Date of Patent: March 26, 2019
    Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Carl E. Wagner, Pamela A. Marshall, Peter W. Jurutka
  • Patent number: 10238626
    Abstract: The invention provides compounds of formula I: and salts thereof, as well as pharmaceutical compositions comprising such compounds. The compounds are useful for treating cancers, Alzheimer's disease, and conditions associated with demyelination.
    Type: Grant
    Filed: January 23, 2018
    Date of Patent: March 26, 2019
    Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Carl E. Wagner, Pamela A. Marshall, Peter W. Jurutka
  • Patent number: 10231947
    Abstract: The invention provides compounds of formula I: and salts thereof, as well as pharmaceutical compositions comprising such compounds. The compounds are useful for treating cancers, Alzheimer's disease, and conditions associated with demyelination.
    Type: Grant
    Filed: January 23, 2018
    Date of Patent: March 19, 2019
    Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Carl E. Wagner, Pamela A. Marshall, Peter W. Jurutka
  • Publication number: 20180207126
    Abstract: The invention provides compounds of formula I: and salts thereof, as well as pharmaceutical compositions comprising such compounds. The compounds are useful for treating cancers, Alzheimer's disease, and conditions associated with demyelination.
    Type: Application
    Filed: January 23, 2018
    Publication date: July 26, 2018
    Inventors: Carl E. Wagner, Pamela A. Marshall, Peter W. Jurutka
  • Publication number: 20180207156
    Abstract: The invention provides compounds of formula I: and salts thereof, as well as pharmaceutical compositions comprising such compounds. The compounds are useful for treating cancers, Alzheimer's disease, and conditions associated with demyelination.
    Type: Application
    Filed: January 23, 2018
    Publication date: July 26, 2018
    Inventors: Carl E. Wagner, Pamela A. Marshall, Peter W. Jurutka
  • Publication number: 20180207125
    Abstract: The invention provides compounds of formula I: and salts thereof, as well as pharmaceutical compositions comprising such compounds. The compounds are useful for treating cancers, Alzheimer's disease, and conditions associated with demyelination.
    Type: Application
    Filed: January 23, 2018
    Publication date: July 26, 2018
    Inventors: Carl E. Wagner, Pamela A. Marshall, Peter W. Jurutka
  • Publication number: 20170182046
    Abstract: The invention provides compounds of formulae I, II, III, and IV: and salts thereof, as well as pharmaceutical compositions comprising such compounds. The compounds are useful for treating cancers and Alzheimer's disease.
    Type: Application
    Filed: January 4, 2017
    Publication date: June 29, 2017
    Applicant: Arizona Board of Regents, A Body Corporate of the State of Arizona, Acting For and On Behalf of Ariz
    Inventors: Carl E. Wagner, Peter W. Jurutka, Pamela A. Marshall
  • Patent number: 9573906
    Abstract: The invention provides compounds of formulae (I), (II), (III), and (IV): and salts thereof, as well as pharmaceutical compositions comprising such compounds. The compounds are useful for treating cancers and Alzheimer's disease.
    Type: Grant
    Filed: September 13, 2012
    Date of Patent: February 21, 2017
    Assignee: Arizona Board of Regents, A Body Corporate of the State of Arizona Acting for and on behalf of Arizona State University
    Inventors: Carl E. Wagner, Peter W. Jurutka, Pamela A. Marshall
  • Patent number: 9174917
    Abstract: The present invention relates to analogs of bexarotene and methods of use thereof.
    Type: Grant
    Filed: February 17, 2011
    Date of Patent: November 3, 2015
    Assignee: Arizona Board of Regents on Behalf of Arizona State University
    Inventors: Carl E. Wagner, Peter W. Jurutka, Pamela A. Marshall, Arjan van der Vaart
  • Publication number: 20140343079
    Abstract: The invention provides compounds of formulae (I), (II), (III), and (IV): and salts thereof, as well as pharmaceutical compositions comprising such compounds. The compounds are useful for treating cancers and Alzheimer's disease.
    Type: Application
    Filed: September 13, 2012
    Publication date: November 20, 2014
    Applicants: Behalf of Arizona State University
    Inventors: Carl E. Wagner, Peter W. Jurutka, Pamela A. Marshall
  • Publication number: 20120309833
    Abstract: The present invention relates to analogs of bexarotene and methods of use thereof.
    Type: Application
    Filed: February 17, 2011
    Publication date: December 6, 2012
    Inventors: Carl E. Wagner, Peter W. Jurutka, Pamela A. Marshall, Arjan van der Vaart
  • Publication number: 20040242542
    Abstract: Small molecule analogues of 1-aminoadamantane and methods for using such compositions to induce CD81-dependent antiproliferative effects and/or for the treatment of disorders of human or veterinary patients and/or for the manufacture of therapeutic preparations used to treat such disorders.
    Type: Application
    Filed: March 25, 2004
    Publication date: December 2, 2004
    Applicant: The Regents of the University of California
    Inventors: Kenneth J. Shea, Carl E. Wagner